Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-094816

EVP, COO acquired 314 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lamothe Jeffrey G. EVP, COO 2024-08-08 Option exercise +42 894 D
Lamothe Jeffrey G. EVP, COO 2024-08-08 Option exercise +272 1,166 D
Derivatives
Lamothe Jeffrey G. EVP, COO 2024-08-08 Option exercise · Restricted Stock Unit −42 41 D
Lamothe Jeffrey G. EVP, COO 2024-08-08 Option exercise · Restricted Stock Unit −272 0 D
Loading xslF345X05/ownership.xml…